Detail akcie Easton Phrmctcl online

Business Summary: Easton Pharmaceuticals, Inc. is a development-stage company engaged in various pharmaceutical sectors and others industries. The Company has a transdermal delivery technology (Viorra Delivery Matrix or VDM), which is incorporated in a line of therapeutic over-the-counter (OTC) products. The Company owns topically-delivered drugs and therapeutic/cosmetic healthcare products focused on cancer and other health problems geared towards female sexual dysfunction, wound healing, pain, motion sickness and other conditions. The Company's products are in various stages of commercialization. The Company's products include Nauseasol, which is a motion sickness gel; Skin Renou HA, which is an anti-aging wrinkle cream; Kenestrin Gel, which is a is a pain relief gel; Viorra, which serves as an aid to the relief of female sexual arousal disorder (FSAD); XILIVE, which is an early-stage cancer drug, and FSAD) drug, which includes a water-based complex polymer matrix.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2020, Easton Pharmaceuticals Inc revenues decreased from $1.6M to $0K. Net loss decreased 42% to $189K. Revenues reflect Service revenue decrease from $1.2M to $0K. Lower net loss reflects Professional fees - lawyer decrease of 89% to $19K (expense), Management fees decrease of 50% to $150K (expense), General and administrative decrease of 64% to $12K (expense).